To the best of our knowledge, this is the first and largest prospective, multicenter study to evaluate the PD-L1 expression status and the association of PD-L1 expression with tumor immune biomarkers in patients with MIUBC using fresh tumor samples in China. Here, CD274 is linked to neoplasm.